Company Information

  

Address: 1 NORTH WAUKEGAN ROAD  
City: NORTH CHICAGO 
State: IL 
Zip Code: 60064 
Telephone: (847) 932-7900 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

AbbVie(1) is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neurology, with additional targeted investment in cystic fibrosis and women's health. AbbVie was incorporated in Delaware on April 10, 2012.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/20183.980.96023.78
12/20173.300.71029.31
09/20174.120.64021.57
06/20175.260.64013.79
03/20175.050.64012.90
12/20164.820.64012.99
09/20163.700.57017.05
06/20163.470.57017.84

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity2.24Total Liab/Total Assets0.93
Net Inc/Total Assets0.08Total Liab/Inv Cap1.38
Net Inc/Inv Cap0.11Total Liab/Comm Equity27.78
Pretax Inc/Net Sales0.27Interest Coverage Ratio8.70
Net Inc/Net Sales0.19Curr Debt/Equity1.26
Cash Flow/Net Sales0.35LTD/Equity6.07
SG&A/NetSales0.22Total Debt/Equity7.33
Asset Utilization   Liquidity  
Net Receivables Turnover5.73Quick Ratio1.18
Inventory Turnover4.62Current Ratio1.28
Inventory Day Sales0.01Net Rec/Curr Assets0.24
Net Sales/Work Cap6.16Inv/Curr Assets0.08
Net Sales/PP&E10.07  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 7,934.00 7,739.00 6,995.00 6,944.00
Cost of Goods Sold 1,927.00 2,280.00 1,616.00 1,528.00
Selling & Admin Exps 1,791.00 1,951.00 1,452.00 1,499.00
Operating Income 2,903.00 1,794.00 2,705.00 2,686.00
Interest Exp 251.00 252.00 252.00 253.00
Pretax Income 2,797.00 1,193.00 2,095.00 2,353.00
Other Income 145.00 -349.00 -358.00 -80.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 2,783.00 52.00 1,631.00 1,915.00

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 9,474.00 9,789.00 9,554.00 7,205.00
Receivables - Total 5,841.00 5,088.00 4,891.00 4,859.00
Inventories - Total 1,738.00 1,605.00 1,785.00 1,582.00
Total Current Assets 20,444.00 21,223.00 18,930.00 16,962.00
Net Property, Plant & Equipment 2,828.00 2,803.00 2,697.00 2,657.00
Total Assets 69,342.00 70,786.00 68,840.00 66,994.00
Liabilities        
Accounts Payable 10,677.00 10,226.00 9,212.00 8,839.00
Debt in Current Liabilities 6,381.00 6,415.00 3,821.00 3,420.00
Total Current Liabilities 17,058.00 16,641.00 13,033.00 12,259.00
Long-Term Debt 30,906.00 30,953.00 33,974.00 33,817.00
Total Liabilities 65,789.00 65,689.00 62,153.00 60,985.00
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 18.00 18.00 18.00 18.00
Retained Earnings 4,977.00 5,459.00 6,547.00 5,951.00
Treasury Stock -13,331.00 -11,923.00 -11,419.00 -11,427.00
Total Stockholders' Equity 3,553.00 5,097.00 6,687.00 6,009.00
Total Liabilities and Stockholders' Equity 69,342.00 70,786.00 68,840.00 66,994.00

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities 2,645.00 2,584.00 3,271.00 2,003.00
Net Cash Provided by Investing Activities -447.00 201.00 -109.00 318.00
Net Cash Provided by Financing Activities -2,509.00 -1,928.00 -810.00 -980.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201318,790.004,128.002.56
12/201419,960.001,774.001.10
12/201522,859.005,144.003.13
12/201625,638.005,953.004.82
12/201728,216.005,309.003.30
Growth Rates10.706.496.55

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional03/31/1821281,122,72570.75




Report Date : 6/18/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.